FinTrust Capital Advisors’s ResMed RMD Stock Holding History

FinTrust Capital Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$24.4K	Hold	100	–	–	﹤0.01%	763
2024 Q2	$19.1K	Hold	100	–	–	﹤0.01%	773
2024 Q1	$19.8K	Hold	100	–	–	﹤0.01%	737
2023 Q4	$17.2K	Hold	100	–	–	﹤0.01%	730
2023 Q3	$14.8K	Hold	100	–	–	﹤0.01%	715
2023 Q2	$20.8K	Hold	100	–	–	0.01%	647
2023 Q1	$20.8K	Hold	100	–	–	0.01%	644
2022 Q4	$20.8K	Hold	100	–	–	0.01%	642
2022 Q3	$22K	Hold	100	–	–	0.01%	701
2022 Q2	$23K	Hold	100	–	–	0.01%	704
2022 Q1	$24K	Hold	100	–	–	0.01%	723
2021 Q4	$26K	Hold	100	–	–	0.01%	669
2021 Q3	$26K	Hold	100	–	–	0.01%	675
2021 Q2	$25K	Hold	100	–	–	0.01%	702
2021 Q1	$19K	Hold	100	–	–	0.01%	735
2020 Q4	$21K	Hold	100	–	–	0.01%	673
2020 Q3	$17	Hold	100	–	–	﹤0.01%	690
2020 Q2	$19K	Hold	100	–	–	0.01%	635
2020 Q1	$15K	Hold	100	–	–	0.01%	689
2019 Q4	$15K	Hold	100	–	–	0.01%	687
2019 Q3	$14K	Hold	100	–	–	﹤0.01%	705
2019 Q2	$12K	Sell	100 -14	-12%	-$1.55K	﹤0.01%	699
2019 Q1	$11K	Sell	114 -26	-19%	-$2.68K	﹤0.01%	764
2018 Q4	$16K	Buy	+140	New	+$15K	0.01%	663

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

FinTrust Capital Advisors's RMD Position: Q3 2024 in Review

FinTrust Capital Advisors held its ResMed (RMD) position steady in Q3 2024 at 100 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #763.

FinTrust Capital Advisors first reported a position in RMD in Q4 2018 and has held it in 24 quarters since. The position peaked at $26K in Q4 2021. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

FinTrust Capital Advisors held 100 shares of ResMed worth $24.4K as of Q3 2024.
FinTrust Capital Advisors left its ResMed share count unchanged in Q3 2024.
ResMed made up ﹤0.01% of FinTrust Capital Advisors's portfolio in Q3 2024, its #763 holding.
FinTrust Capital Advisors first reported a position in ResMed in Q4 2018 and has held it in 24 quarters since.
FinTrust Capital Advisors's ResMed position peaked at $26K in Q4 2021.
801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.